Advanced search
Publication Cover
Modern Rheumatology Volume 23, 2013 - Issue 4
Journal homepage
60
Views
13
CrossRef citations to date
0
Altmetric
Original Article

The effect of methotrexate on improving serological abnormalities of patients with systemic lupus erythematosus

Shoji MiyawakiRheumatic Disease Center, Kurashiki Medical Center, 250 Bakuro-cho, Kurashiki, Okayama 710-8522, JapanCorrespondence[email protected]
,
Susumu NishiyamaRheumatic Disease Center, Kurashiki Medical Center, 250 Bakuro-cho, Kurashiki, Okayama 710-8522, Japan
,
Tetsushi AitaRheumatic Disease Center, Kurashiki Medical Center, 250 Bakuro-cho, Kurashiki, Okayama 710-8522, Japan
&
Yasuhiko YoshinagaRheumatic Disease Center, Kurashiki Medical Center, 250 Bakuro-cho, Kurashiki, Okayama 710-8522, Japan
Pages 659-666 | Received 29 Nov 2011, Accepted 14 Jun 2012, Published online: 02 Jan 2014

REFERENCES

  • Jolivet J, Cowan KH, Curt GA, Clendeninn NJ, Chabner BA. The pharmacology and clinical use of methotrexate. N Engl J Med. 1983;309:1094–104.
  • Braun J, Rau R. An update on methotrexate. Curr Opin Rheum. 2009;21:216–23.
  • Rothenberg RJ, Graziano FM, Grandone JT, Goldenberg JW, Bjamason DF, Finesilver AG. The use of methotrexate in steroid-resistant systemic lupus erythematosus. Arthritis Rheum. 1988;31:612–5.
  • Wilson K, Abeles M. A 2 year, open ended trial of methotrexate in systemic lupus erythematosus. J Rheumatol. 1994;21:1674–7.
  • Wise CM, Vuyyuru S, Roberts WN. Methotrexate in nonrenal lupus and undifferentiated connective tissue disease-a review of 36 patients. J Rheumatol. 1996;23: 1005–10.
  • Rahman P, Humphrey-Murto S, Gladman DD, Urowitz MB. Efficacy and tolerability of methotrexate in antimalarial resistant lupus arthritis. J Rheumatol. 1998;25:243–6.
  • Carneiro JRM, Sato EL. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus ery-thematosus. J Rheumatol. 1999;26:1275–9.
  • Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum. 1992;35:630–40.
  • Gansauge S, Breitbart A, Rinaldi N, Schwarz-Eywill M. Meth-otrexate in patients with moderate systemic lupus erythematosus (exclusion of renal and central nervous system disease). Ann Rheum Dis. 1997;56:382–5.
  • Fortin PR, Abrahamowicz M, Ferland D, Lacaille D, Smith CD, Zummer M. Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blinded, randomized, placebo-controlled trial. Arthritis Rheum. 2008;59:1796–804.
  • Schur PH, Swanson J. Immunologic factors and clinical activity in systemic erythematosus. N Engl J Med. 1968;278:533–8.
  • Lloyd W, Schur PH. Immune complexes, complement, and anti-dsDNA in exacerbations of systemic lupus erythematosus (SLE). Medicine. 1981;60:208–17.
  • Swaak MG, Gorenwold J, Bronsveld W. Predictive value of complement profiles and anti-dsDNA in systemic lupus erythe-matosus. Ann Rheum Dis. 1986;45:359–66.
  • Sullivan KE, Wisnieski JJ, Winkelstein JA, Louie J, Sachs E, Choi R, et al. Serum complement determinations in patients with quiescent systemic lupus erythematosus. J Rheumatol. 1996;23: 2063–7.
  • Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of SLE. Arthritis Rheum. 1983;25:1271–7.
  • Yamanaka H, Inoue E, Tanaka E, Nakajima A, Taniguchi A, Terai C, et al. Influence of methotrexate dose on its efficacy and safety in rheumatoid arthritis patients: evidence based on the variety of prescribing approaches among practicing Japanese rheumatologists in a single institute-based large observation cohort (IORRA). Mod Rheumatol. 2007;17:98–105.
  • Glantz SA. Primers of biostatistics. 5th ed. NY: McGraw-Hill, Inc. Health Professions Division; 2002. p. 89–90.
  • Ravelli A, Ballardini G, Viola S, Villa I, Ruperto N, Martini A. Methotrexate therapy in refractory pediatric onset systemic lupus erythematosus. J Rheumatol. 1998;25:572–5.
  • Galarza D, Esquivel J, Villarreal M, de la Garza N, Garza M. Methotrexate in lupus nephritis: an uncontrolled study, preliminary results. Arthritis Rheum. 1992;34;187 (abstract D140).
  • Abud-Mendoza C, Sturbaum AK, Vazquez-Compean P, Gonz-alez-Amaro R. Methotrexate therapy in childhood systemic lupus erythematosus. J Rheumatol. 1993;20:731–3.
  • Smeenk RJ, van den Brink HG, Brinkman K, Termaat RM, Berden JH, Swaak AJ. Anti-dsDNA: choice of assay in relation to clinical value. Rheumatol Int. 1991;11:101–7.
  • Hahn BH, Tsao BP. Antibodies to DNA. In: Wallace DJ, Hahn BH, editors. Dubois' lupus erythematosus. Philadelphia: Lippin-cott Williams & Wilkins; 2002. p. 425–45.
  • Neogi T, Gladman DD, Ibanez D, Urowitz MB. Anti-dsDNA antibody testing by Fan and ELISA techniques is not equivalent. J Rheumatol. 2006;33:1785–8.
  • Steinman AJ, Gladman DD, Ibanez D, Urowitz MB. Prolonged serologically active clinically quiescent systemic lupus erythe-matosus: frequency and outcome. J Rheumatol. 2010;37:1822–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.